Fidelity Investments’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,076,506
| Closed | -$9.87M | – | 5450 |
|
|
2025
Q1 | $9.87M | Buy |
1,076,506
+4,307
| +0.4% | +$27K | ﹤0.01% | 1919 |
|
|
2024
Q4 | $7.16M | Sell |
1,072,199
-30,591
| -3% | -$269K | ﹤0.01% | 2042 |
|
|
2024
Q3 | $11.1M | Buy |
1,102,790
+34,574
| +3% | +$504K | ﹤0.01% | 1886 |
|
|
2024
Q2 | $16.7M | Buy |
1,068,216
+97,028
| +10% | +$1.63M | ﹤0.01% | 1707 |
|
|
2024
Q1 | $21.3M | Sell |
971,188
-6,608
| -0.7% | -$147K | ﹤0.01% | 1630 |
|
|
2023
Q4 | $18.9M | Sell |
977,796
-12,129
| -1% | -$221K | ﹤0.01% | 1649 |
|
|
2023
Q3 | $18.3M | Buy |
989,925
+3,171
| +0.3% | +$57.1K | ﹤0.01% | 1617 |
|
|
2023
Q2 | $18.2M | Sell |
986,754
-3,611
| -0.4% | -$85.4K | ﹤0.01% | 1684 |
|
|
2023
Q1 | $28.7M | Buy |
990,365
+12,958
| +1% | +$345K | ﹤0.01% | 1469 |
|
|
2022
Q4 | $27.1M | Buy |
977,407
+144,632
| +17% | +$5.49M | ﹤0.01% | 1497 |
|
|
2022
Q3 | $45.7M | Buy |
832,775
+5,965
| +0.7% | +$327K | ﹤0.01% | 1275 |
|
|
2022
Q2 | $45.4M | Buy |
826,810
+2,637
| +0.3% | +$97K | ﹤0.01% | 1313 |
|
|
2022
Q1 | $30.5M | Buy |
824,173
+26,669
| +3% | +$952K | ﹤0.01% | 1600 |
|
|
2021
Q4 | $19.4M | Buy |
797,504
+264,414
| +50% | +$8.85M | ﹤0.01% | 1836 |
|
|
2021
Q3 | $24M | Buy |
533,090
+1,964
| +0.4% | +$82.4K | ﹤0.01% | 1753 |
|
|
2021
Q2 | $24.8M | Buy |
531,126
+1,667
| +0.3% | +$85.1K | ﹤0.01% | 1752 |
|
|
2021
Q1 | $29.3M | Buy |
529,459
+8,654
| +2% | +$526K | ﹤0.01% | 1625 |
|
|
2020
Q4 | $32.3M | Buy |
520,805
+882
| +0.2% | +$54K | ﹤0.01% | 1494 |
|
|
2020
Q3 | $30.4M | Buy |
519,923
+60,861
| +13% | +$4.51M | ﹤0.01% | 1390 |
|
|
2020
Q2 | $51.2M | Hold |
459,062
| – | – | 0.01% | 1152 |
|
|
2020
Q1 | $30.9M | Buy |
459,062
+645
| +0.1% | +$65K | ﹤0.01% | 1226 |
|
|
2019
Q4 | $63.4M | Buy |
458,417
+44,058
| +11% | +$5.71M | 0.01% | 1110 |
|
|
2019
Q3 | $43.5M | Buy |
414,359
+1,715
| +0.4% | +$171K | 0.01% | 1224 |
|
|
2019
Q2 | $43.8M | Hold |
412,644
| – | – | 0.01% | 1285 |
|
|
2019
Q1 | $63.8M | Buy |
412,644
+374
| +0.1% | +$43.4K | 0.01% | 1109 |
|
|
2018
Q4 | $38.3M | Buy |
412,270
+64
| +0% | +$9.14K | 0.01% | 1259 |
|
|
2018
Q3 | $76.9M | Buy |
412,206
+4,392
| +1% | +$1.25M | 0.01% | 1065 |
|
|
2018
Q2 | $171M | Buy |
407,814
+29,183
| +8% | +$9.84M | 0.02% | 726 |
|
|
2018
Q1 | $112M | Buy |
378,631
+481
| +0.1% | +$133K | 0.01% | 935 |
|
|
2017
Q4 | $103M | Buy |
+378,150
| New | +$106M | 0.01% | 986 |
|
Fidelity Investments's OPTN Position: Q2 2025 in Review
Fidelity Investments sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 1,076,506 shares — an estimated $9.87M sold.
Fidelity Investments first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $171M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Fidelity Investments reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Fidelity Investments sold 1,076,506 OptiNose shares in Q2 2025, an estimated $9.87M.
- Fidelity Investments first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
- Fidelity Investments's OptiNose position peaked at $171M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.